- Morgan Stanley increased its price target for UnitedHealth Group (NYSE: UNH) to $453.00, indicating strong analyst confidence.
- Bank of America upgraded UnitedHealth Group to a “buy” rating, setting a new price target of $450.00.
- The stock demonstrates a potential upside of over 20%, reflecting positive sentiment in the healthcare sector.
UnitedHealth Group is a major company in the health insurance industry, providing comprehensive health care coverage and benefits services. With a substantial market capitalization of about $342.37 billion, it stands as one of the biggest players in the healthcare sector, managing health care for millions of people.
On June 4, 2026, Morgan Stanley analyst Erin Wright increased the price target for UnitedHealth Group to $453.00. A price target is an analyst’s projection of a stock’s future price. At the time, UnitedHealth Group was trading at $377.00 per share, showing positive sentiment from the financial firm.
This new price target suggests a potential upside of about 20.16%. This means the analyst believes the stock’s value could grow by that percentage from its $377.00 price. This projection often influences how investors view a stock’s potential for future growth.
This positive view is shared by others. Bank of America also upgraded UnitedHealth Group to a “buy” rating from “neutral” and raised its price target to $450.00 from $420.00. Following this news, the stock increased 2.7% to $387.01 in premarket trading, as highlighted by Schaeffer’s Research.
Currently, UnitedHealth Group trades at $377.00 per share. The stock’s price has moved between a low of $376.83 and a high of $387.46 during the day. Over the last year, its price has ranged from a 52-week low of $234.60 to a high of $404.15.
